Paris
France
14
2021-03-18
11
2022-06-07
These are the the leading inventors for applications assigned to INVECTYS:
INVECTYS based in Paris, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Recombinant measles vaccine expressing hTERT
#2 | 2019-08-01ANTI HLA-G SPECIFIC ANTIBODIES
#3 | 2019-06-13CANCER VACCINE FOR DOGS
#4 | 2019-01-03 β Patent 12,064,474 granted on 2024-08-20Telomerase encoding DNA vaccine
#5 | 2018-09-27 β Patent 10,675,337 granted on 2020-06-09Cancer vaccine for cats
#6 | 2018-09-06POLYEPITOPE CONSTRUCTS FOR USE IN IMMUNOTHERAPY
#7 | 2017-12-21 β Patent 10,695,409 granted on 2020-06-30Universal cancer peptides derived from telomerase
#8 | 2016-09-29 β Patent 10,493,154 granted on 2019-12-03Gene electrotransfer into skin cells
#9 | 2016-09-22 β Patent 10,005,845 granted on 2018-06-26Antibodies and fragments thereof raised against the alpha-3 domain of HLA-G protein, methods and means for their preparation, and uses thereof
#10 | 2016-09-15 β Patent 10,183,065 granted on 2019-01-22Telomerase encoding DNA vaccine
#11 | 2016-05-05 β Patent 10,010,591 granted on 2018-07-03Method of treating fibrosarcoma using a nucleic acid sequence encoding APOBEC3A
#12 | 2016-02-25 β Patent 9,931,387 granted on 2018-04-03Cancer vaccine for cats
#13 | 2016-02-18 β Patent 10,138,488 granted on 2018-11-27Cancer vaccine for dogs
#14 | 2015-10-08 β Patent 9,669,080 granted on 2017-06-06Universal cancer peptides derived from telomerase
Also check out INVECTYS's (Paris, France) applicant profile with 10 patent applications submitted.
99680 β